Group 1 - The company announced a share repurchase plan with a total amount between RMB 150 million and RMB 300 million, with a repurchase price cap adjusted to RMB 19.77 per share after a dividend distribution [2][3] - As of September 2025, the company has repurchased a total of 1,138,950 shares, accounting for approximately 0.05% of the total share capital, with a total expenditure of RMB 18,338,151 [3][4] Group 2 - The company's consolidated revenue for September 2025 was RMB 5,958,939,681.16, representing a year-on-year increase of 0.10% and a month-on-month increase of 7.23% [8] - For the first nine months of 2025, the consolidated revenue was RMB 43,641,175,541.80, a decrease of 0.83% compared to the same period last year [8] - The consolidated revenue for the third quarter of 2025 was RMB 16,427,474,248.20, a year-on-year decrease of 1.16% but a quarter-on-quarter increase of 21.10% [8] Group 3 - In the third quarter of 2025, the company converted RMB 24,000 of convertible bonds into 1,288 shares, with a total of RMB 3,449,797,000 of convertible bonds remaining unconverted, accounting for 99.9941% of the total issuance [10][15] - The stock option incentive plan saw 4,667,160 shares exercised in the third quarter of 2025, with a total of 14,553,565 shares exercised since the plan's inception [11][36] Group 4 - The company has made adjustments to the stock option incentive plan due to changes in the number of eligible participants and performance evaluations, resulting in a reduction of the total number of options granted [19][25] - The exercise price for the 2023 stock option incentive plan was adjusted to RMB 14.04 per share for the third quarter of 2025 [33][36]

Core Viewpoint - Jiangsu Zhongtian Technology Co., Ltd. has announced the progress of its fifth share repurchase plan, detailing the implementation and current status of the repurchase initiative [1] Summary by Sections Repurchase Plan Review - The company approved a share repurchase plan on November 5, 2024, using its own and self-raised funds, with a total repurchase amount between 200 million yuan and 400 million yuan, and a maximum repurchase price of 22 yuan per share [2] - Due to the profit distribution in 2024, the maximum repurchase price was adjusted to 21.7 yuan per share starting July 25, 2025 [2] Repurchase Progress - As of September 30, 2025, the company has repurchased a total of 18.79 million shares, accounting for 0.5506% of the current total share capital [3] - The highest transaction price for the repurchase was 14.8 yuan per share, while the lowest was 12.6 yuan per share, with a total payment of approximately 252.29 million yuan [3] - On August 4, 2025, the company received a transfer confirmation for 15.11 million shares to the third employee stock ownership plan account [3] Future Plans - The company will make repurchase decisions based on market conditions within the repurchase period and will fulfill its information disclosure obligations in a timely manner [4]

Group 1 - The core announcement is about Qianwei Yangchu's share repurchase progress as of October 10, 2025 [1] Group 2 - The share repurchase plan was approved during board meetings on April 25 and May 20, 2025, with a total budget set between 40 million yuan and 60 million yuan, and a maximum repurchase price of 43.21 yuan per share [2] - The repurchase period is set for 12 months from the date of shareholder meeting approval [2] Group 3 - As of September 30, 2025, Qianwei Yangchu has repurchased a total of 248,500 shares, representing 0.26% of the total share capital, with a total transaction amount of 8,991,611 yuan [3] - The highest transaction price during the repurchase was 39.73 yuan per share, while the lowest was 32.35 yuan per share [3]

Core Viewpoint - Nanjing Pharmaceutical has announced the progress of its share repurchase plan, which aims to utilize self-owned or raised funds to buy back shares for the implementation of its 2025 restricted stock incentive plan [2][3]. Summary by Sections Repurchase Plan Overview - On March 14, 2025, Nanjing Pharmaceutical's board approved a share repurchase plan, with the first disclosure on March 15, 2025. The repurchase period is set from March 14, 2025, to March 14, 2026. The expected repurchase amount is between 70 million yuan (approximately 10.1 million USD) and 131.58 million yuan (approximately 18.8 million USD), with a maximum repurchase price of 7.31 yuan (approximately 1.05 USD) per share [2]. Repurchase Progress Details - As of the announcement date, the company has repurchased a total of 16,299,951 shares, accounting for 1.25% of the total share capital, with a cumulative repurchase amount of 80.2576 million yuan (approximately 11.5 million USD). The actual repurchase price ranged from 4.69 yuan (approximately 0.67 USD) to 5.22 yuan (approximately 0.75 USD) per share. The total share capital increased from 1,308,928,704 shares at the end of August 2025 to 1,308,929,289 shares at the end of September 2025 due to the conversion of convertible bonds [3]. Future Plans - Nanjing Pharmaceutical will adhere to relevant regulations and guidelines during the repurchase period and will make repurchase decisions based on market conditions while fulfilling its information disclosure obligations in a timely manner [4].

Group 1 - The core point of the article is the announcement by Zhejiang Haizheng Pharmaceutical Co., Ltd. regarding the progress of its fourth share repurchase plan through centralized bidding [1] Group 2 - The key information of the repurchase plan includes a total repurchase fund of no less than 50 million yuan and no more than 100 million yuan, with a maximum repurchase price of 13 yuan per share, and the repurchase period from May 12, 2025, to May 11, 2026 [2] Group 3 - As of the end of September 2025, the company has repurchased a total of 5.535 million shares, accounting for 0.46% of the total share capital, with an actual repurchase price range between 8.92 yuan and 9.40 yuan per share, totaling 50,891,385 yuan paid (excluding transaction fees) [3] - The company did not conduct any share repurchases in September 2025, but it stated that it will strictly follow relevant regulations and make repurchase decisions based on market conditions within the repurchase period [3]

登录新浪财经APP 搜索【信披】查看更多考评等级 宏微科技（维权）于2025年10月10日发布关于第二期以集中竞价方式回购公司股份的进展公告，披露了 回购相关重要信息。 回购方案概况 2024年12月4日，宏微科技召开第五届董事会第五次会议，审议通过以集中竞价交易方式回购公司股份 方案。公司拟使用自有资金和股票回购专项贷款进行回购，资金总额不低于2500万元（含），不超过 5000万元（含）。回购股份将用于股权激励或员工持股计划，或用于转换公司可转债，回购价格不超过 30.12元/股（含）。回购期限自董事会审议通过之日起不超过12个月，即2025年12月4日至2025年12月3 日，回购方案首次披露日为2024年12月6日。 截至2025年9月月底，公司已累计回购股份1313216股，占总股本213082131股的0.6163% 。实际回购价 格区间为13.00元/股至26.53元/股，已支付总金额2301.56万元（不含交易佣金等费用）。其中，2025年9 月，公司通过集中竞价交易方式累计回购股份0股。 宏微科技表示，本次回购符合相关法律法规规定和公司回购股份方案要求。后续，公司将严格按规定， 在回购期限内 ...

Group 1 - The core point of the article is that Taishan Petroleum announced the progress of its share repurchase plan, indicating that as of September 30, 2025, the company has not yet implemented the repurchase [1][3]. Group 2 - On April 23 and May 21, 2025, Taishan Petroleum's board and annual shareholders' meeting approved a plan to repurchase A-shares using self-owned funds, with a total repurchase budget set between RMB 25 million and RMB 35 million [2]. - The maximum repurchase price is capped at RMB 8.99 per share, and the repurchase period is set to not exceed 12 months from the approval date [2]. - The company is required to disclose the progress of the repurchase within the first three trading days of each month, as per relevant regulations [3].

Core Points - The company, Zhao Xun Media Advertising Co., Ltd., has approved a share repurchase plan with a total fund amounting to no less than 100 million yuan and no more than 200 million yuan, with a maximum repurchase price of 14.80 yuan per share [1] - The repurchase price cap will be adjusted to no more than 14.78 yuan per share starting from June 18, 2025, due to the implementation of the 2024 annual equity distribution plan [1] - As of September 30, 2025, the company has repurchased a total of 5,220,075 shares, accounting for 1.29% of the total share capital, with a total transaction amount of 60,003,310.31 yuan [1] Summary by Sections Share Repurchase Plan - The company plans to use its own funds for the share repurchase aimed at employee stock ownership plans or equity incentives [1] - The implementation period for the repurchase plan is set to be no more than 12 months from the board's approval date [1] Compliance and Execution - The timing, quantity, price, and trading method of the share repurchase comply with relevant regulations and the company's repurchase plan [2] - The company has not repurchased shares during any significant events that could impact the stock price before legally disclosing such events [2] Market Response - The company will continue to advance the repurchase plan based on market conditions and will fulfill its information disclosure obligations as required [2]

登录新浪财经APP 搜索【信披】查看更多考评等级 根据相关规定，在回购期间，回购股份占上市公司总股本的比例每增加1%的，应当在事实发生之日起3 个交易日内予以披露。此次回购符合相关法律法规的规定及公司回购方案的要求。 后续计划 公司表示，将严格按照《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引第7号—— 回购股份》等相关规定，在回购期限内根据市场情况择机做出回购决策并予以实施，同时根据回购股份 事项进展情况及时履行信息披露义务。投资者需注意投资风险。 声明：市场有风险，投资需谨慎。 本文为AI大模型基于第三方数据库自动发布，任何在本文出现的信 息（包括但不限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成 个人投资建议。受限于第三方数据库质量等问题，我们无法对数据的真实性及完整性进行分辨或核验， 因此本文内容可能出现不准确、不完整、误导性的内容或信息，具体以公司公告为准。如有疑问，请联 系biz@staff.sina.com.cn。 点击查看公告原文>> 责任编辑：小浪快报 湖南海利化工股份有限公司于2025年10月10日发布公告，披露以集中竞价交易方式回购股份比例达 ...

Core Points - The company, Shuangta Food, announced the progress of its share repurchase plan as of the end of last month, revealing details about the implementation of the plan [1] - The board approved a share repurchase plan on April 21, 2025, with a budget set between 200 million RMB and 300 million RMB, aimed at incentivizing employees through stock ownership plans [1] - The maximum repurchase price was initially set at 7.95 RMB per share, later adjusted to 7.93 RMB due to a dividend distribution announcement [1] Repurchase Plan Details - The repurchase plan is to be executed within six months from the board's approval date, using both self-owned funds and special loans for share repurchase [1] - As of the announcement, the lowest transaction price was 5.03 RMB per share, with a total expenditure of approximately 158.4 million RMB, which complies with the company's repurchase plan and relevant regulations [1] - The company confirmed that the timing, quantity, and price of the repurchase are in accordance with the Shenzhen Stock Exchange's regulations [2] Future Actions - The company will continue to implement the repurchase based on market conditions and will fulfill its information disclosure obligations in a timely manner [2] - Investors are advised to pay attention to future announcements regarding the repurchase plan [2]